News Search Results
Sep 17, 2025, 10:32 ET Radiance Technologies, LSU Health Shreveport, and LA Tech Unite for $5.85M DARPA Contract to Fuel Defense Biology Innovations
Radiance's first collaboration with DARPA BTO and establishes North Louisiana as an emerging hub for cutting-edge biotechnology research. The project, named "Crowded, Heterogeneous, Intracellular, and Multi-Scale Environments for Revolutionary Bio-Applications (CHIMERA)," aims
More news about: Radiance Technologies
Sep 17, 2025, 10:24 ET Anti-Money Laundering Market Is Projected to Reach US$ 13.54 Billion By 2031 with CAGR Of 18.3% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 17, 2025, 10:12 ET Global EV Battery Recycling Market Predicted to Reach $24.5 Billion by 2035 with CAGR 40.80% | A Strategic Inflection Point for Circular Economy, EV Sustainability, and Energy Security
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 17, 2025, 09:42 ET Lung Cancer Pioneer Dr. Gilberto Lopes Joins Longevity Company Immorta Bio
the translation of this innovative science to patients." About Immorta BioImmorta Bio Inc. is a longevity-focused biotechnology company developing personalized cellular and immune therapeutics aimed at "Treating Diseases of Aging and Treating Aging as Disease™." The
More news about: Immorta Bio Inc.
Sep 17, 2025, 09:00 ET Mana.bio Unveils Mina™,The World's First Large Language Model-Powered AI Agent for Lipid Nanoparticles
TEL AVIV, Israel, Sept. 17, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™, the world's first large language
More news about: Mana.bio
Sep 17, 2025, 09:00 ET Mana.bio Unveils Mina™,The World's First Large Language Model-Powered AI Agent for Lipid Nanoparticles
TEL AVIV, Israel, Sept. 17, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™, the world's first large language
More news about: Mana.bio
Sep 17, 2025, 09:00 ET Lilly's oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 17, 2025, 08:47 ET Frame Bio Licenses Novel Drug Delivery Technology from Mercury Bio to Develop Regenerative Therapies for Bone and Collagen Diseases and Disorders
Frame Bio, a biotechnology company developing therapeutics for structural diseases and disorders, announced today an exclusive licensing agreement with
More news about: Frame Bio LLC
Sep 17, 2025, 08:30 ET Advancing Cancer Research Brings New Hope for Patients Worldwide
and CEO Dr. Vuong Trieu, the company is applying AI, nanomedicine and innovative clinical approaches to reimagine biotechnology. Anchored by a strong intellectual property portfolio, including some 500 patent applications and 75 granted patents, Oncotelic is assembling a
More news about: NetworkNewsWire
Sep 17, 2025, 08:00 ET Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets, today announced positive results from the first interim
More news about: Skyhawk Therapeutics
Sep 17, 2025, 07:32 ET Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon Biologics
Sep 17, 2025, 03:00 ET ARTHEx Biotech Upsizes Series B Financing Round to $87M to Advance Lead Program ATX-01 in Myotonic Dystrophy Type 1 and Expand Pipeline of Targeted RNA Medicines
Spain, Sept. 17, 2025 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing targeted RNA medicines for rare genetic neuromuscular disorders, today announced the successful closing of its upsized
More news about: ARTHEx Biotech
Sep 16, 2025, 19:30 ET Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
until 2044 without patent extensions. About Ascletis Pharma Inc. Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Sep 16, 2025, 18:01 ET Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 16, 2025, 12:05 ET Inari Announces New Chief Commercial Officer, Rob Dunlop
Dunlop brings more than 30 years of experience, spanning agribusiness, breeding, agronomy and biotechnology. He most recently served as Vice President, North America Seed at Nutrien Ag Solutions, with additional senior leadership roles at Bayer Crop Science
More news about: Inari
Sep 16, 2025, 11:14 ET Sanguine Expands Oncology Biospecimen Offerings Through Strategic Clinic Partnerships
and scientists working on innovative therapies. In supporting translational and clinical research at 30 of the top 40 global pharmaceutical and biotechnology companies, Sanguine has accelerated R&D and increased confidence in drug development and manufacturing pipelines. For the past four years, Sanguine
More news about: Sanguine Biosciences
Sep 16, 2025, 10:34 ET Asia New Vision Forum 2025 Opens in Singapore, Gathers Global Leaders to Chart the Future Amid Uncertainty
topics like geopolitics and financial markets and diverse dialogues on the key growth engines, namely, frontiers in artificial intelligence and biotechnology, urgent demands of the energy transition, and the future of advanced manufacturing and consumption. Senior executives from leading biotech, pharmaceutical,
More news about: Caixin
Sep 16, 2025, 10:30 ET Lilly announces plans to build $5 billion manufacturing facility in Virginia
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 16, 2025, 10:30 ET Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 16, 2025, 10:17 ET Solid-State Battery Market Size & Share to Surpass $56.05 Billion by 2035, Growing at a CAGR 42.5% | A Strategic Inflection Point for EVs, Energy Security, and Next-Gen Electronics
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 16, 2025, 10:02 ET Connect Life Sciences Announces Scott Dalton as New CEO
Scott Dalton as Chief Executive Officer. CLS is a leading provider of workforce solutions serving the pharmaceutical, biotechnology, and medical device industries.
More news about: Argosy Healthcare Partners
Sep 16, 2025, 10:01 ET Cybersecurity Market Is Projected To Reach US$552.35 Billion By 2031 With CAGR Of 13.8% | The Insight Partners
syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact
More news about: The Insight Partners
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Sep 16, 2025, 10:00 ET Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics
More news about: Roche
Sep 16, 2025, 09:55 ET Unlocking the Body's Natural Healing Power: New Publication Reveals Breakthroughs in Regenerative Medicine
Dr. Sand, a biotechnology and regenerative medicine consultant with more than two decades of experience, reviewed in the publication a broad spectrum of clinical studies
More news about: QC Kinetix